Seeing Is Believing
with an average price target of $43.44. This is a potential upside of $43.44 (0%) from yesterday's end of day stock price of $0.
Viridian Therapeutics's activity chart (see below) currently has 11 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.22% with an average time for these price targets to be met of 70.33 days.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 30-Dec-2020. First documented stock forecast 20-Feb-2017.
11/13/20 1 for 15
5/16/01 11 for 10
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$37
$19 (105.56%)
$2
4 years 9 months 26 days ago
(30-Dec-2020)
1/3 (33.33%)
$20.55 (124.92%)
189
Buy
$15
$-3 (-16.67%)
5 years 21 days ago
(05-Oct-2020)
1/3 (33.33%)
$6.28 (72.02%)
22
Hold
$240
5 years 10 months 15 days ago
(11-Dec-2019)
0/2 (0%)
$103.5 (75.82%)
What is MGEN (Viridian Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MGEN (Viridian Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MGEN (Viridian Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MGEN (Viridian Therapeutics)?
Which analyst is the currently most bullish on MGEN (Viridian Therapeutics)?
Which analyst is the currently most reserved on MGEN (Viridian Therapeutics)?